Literature DB >> 31682559

Detecting Emerging Infectious Diseases: An Overview of the Laboratory Response Network for Biological Threats.

Julie Villanueva1, Beth Schweitzer1, Marcella Odle1, Tricia Aden1.   

Abstract

The Laboratory Response Network (LRN) was established in 1999 to ensure an effective laboratory response to high-priority public health threats. The LRN for biological threats (LRN-B) provides a laboratory infrastructure to respond to emerging infectious diseases. Since 2012, the LRN-B has been involved in 3 emerging infectious disease outbreak responses. We evaluated the LRN-B role in these responses and identified areas for improvement. LRN-B laboratories tested 1097 specimens during the 2014 Middle East Respiratory Syndrome Coronavirus outbreak, 180 specimens during the 2014-2015 Ebola outbreak, and 92 686 specimens during the 2016-2017 Zika virus outbreak. During the 2014-2015 Ebola outbreak, the LRN-B uncovered important gaps in biosafety and biosecurity practices. During the 2016-2017 Zika outbreak, the LRN-B identified the data entry bottleneck as a hindrance to timely reporting of results. Addressing areas for improvement may help LRN-B reference laboratories improve the response to future public health emergencies.

Entities:  

Keywords:  bioterrorism; counterterrorism; emergency preparedness; emerging infectious diseases; laboratory; public health preparedness; terrorism

Mesh:

Year:  2019        PMID: 31682559      PMCID: PMC6832029          DOI: 10.1177/0033354919874354

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  9 in total

1.  Update: Interim Guidelines for Health Care Providers Caring for Infants and Children with Possible Zika Virus Infection--United States, February 2016.

Authors:  Katherine E Fleming-Dutra; Jennifer M Nelson; Marc Fischer; J Erin Staples; Mateusz P Karwowski; Paul Mead; Julie Villanueva; Christina M Renquist; Anna A Minta; Denise J Jamieson; Margaret A Honein; Cynthia A Moore; Sonja A Rasmussen
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-02-26       Impact factor: 17.586

Review 2.  Clinical recognition and management of patients exposed to biological warfare agents.

Authors:  D R Franz; P B Jahrling; A M Friedlander; D J McClain; D L Hoover; W R Bryne; J A Pavlin; G W Christopher; E M Eitzen
Journal:  JAMA       Date:  1997-08-06       Impact factor: 56.272

3.  Leveraging the laboratory response network model for the global health security agenda.

Authors:  Chris N Mangal; Lucy Maryogo-Robinson
Journal:  Biosecur Bioterror       Date:  2014 Sep-Oct

Review 4.  West Africa 2013 Ebola: From Virus Outbreak to Humanitarian Crisis.

Authors:  Daniel G Bausch
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

5.  Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus.

Authors:  Xiaoyan Lu; Brett Whitaker; Senthil Kumar K Sakthivel; Shifaq Kamili; Laura E Rose; Luis Lowe; Emad Mohareb; Emad M Elassal; Tarek Al-sanouri; Aktham Haddadin; Dean D Erdman
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

6.  Update: Interim Guidance for the Evaluation and Management of Infants with Possible Congenital Zika Virus Infection - United States, August 2016.

Authors:  Kate Russell; Sara E Oliver; Lillianne Lewis; Wanda D Barfield; Janet Cragan; Dana Meaney-Delman; J Erin Staples; Marc Fischer; Georgina Peacock; Titilope Oduyebo; Emily E Petersen; Sherif Zaki; Cynthia A Moore; Sonja A Rasmussen
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-08-26       Impact factor: 17.586

7.  Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection - United States, 2016.

Authors:  J Erin Staples; Eric J Dziuban; Marc Fischer; Janet D Cragan; Sonja A Rasmussen; Michael J Cannon; Meghan T Frey; Christina M Renquist; Robert S Lanciotti; Jorge L Muñoz; Ann M Powers; Margaret A Honein; Cynthia A Moore
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-01-29       Impact factor: 17.586

8.  Evaluation of Patients under Investigation for MERS-CoV Infection, United States, January 2013-October 2014.

Authors:  Eileen Schneider; Christina Chommanard; Jessica Rudd; Brett Whitaker; Luis Lowe; Susan I Gerber
Journal:  Emerg Infect Dis       Date:  2015-07       Impact factor: 6.883

9.  Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States (Including U.S. Territories), July 2017.

Authors:  Titilope Oduyebo; Kara D Polen; Henry T Walke; Sarah Reagan-Steiner; Eva Lathrop; Ingrid B Rabe; Wendi L Kuhnert-Tallman; Stacey W Martin; Allison T Walker; Christopher J Gregory; Edwin W Ades; Darin S Carroll; Maria Rivera; Janice Perez-Padilla; Carolyn Gould; Jeffrey B Nemhauser; C Ben Beard; Jennifer L Harcourt; Laura Viens; Michael Johansson; Sascha R Ellington; Emily Petersen; Laura A Smith; Jessica Reichard; Jorge Munoz-Jordan; Michael J Beach; Dale A Rose; Ezra Barzilay; Michelle Noonan-Smith; Denise J Jamieson; Sherif R Zaki; Lyle R Petersen; Margaret A Honein; Dana Meaney-Delman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-07-28       Impact factor: 17.586

  9 in total
  4 in total

1.  Advancing the Public Health Laboratory System Through Partnerships.

Authors:  Kirsten St George; Renée Ned-Sykes; Reynolds Salerno; Michael A Pentella
Journal:  Public Health Rep       Date:  2019 Nov/Dec       Impact factor: 2.792

Review 2.  The U.S. national biomonitoring network - Enhancing capability and capacity to assess human chemical exposures.

Authors:  Julianne Nassif; Antonia M Calafat; Kenneth M Aldous
Journal:  Int J Hyg Environ Health       Date:  2021-08-25       Impact factor: 7.401

Review 3.  Main Factors Affecting the Readiness and Responsiveness of Healthcare Systems during Epidemic Crises: A Scoping Review on Cases of SARS, MERS, and COVID-19.

Authors:  Mohammadtaghi Mohammadpour; Effat Zarifinezhad; Arash Ghanbarzadegan; Khodadad Naderimanesh; Nasrin Shaarbafchizadeh; Peivand Bastani
Journal:  Iran J Med Sci       Date:  2021-03

4.  Rapid Diagnostic Testing for Response to the Monkeypox Outbreak - Laboratory Response Network, United States, May 17-June 30, 2022.

Authors:  Tricia A Aden; Patricia Blevins; Shannon Whitman York; Stacy Rager; Devika Balachandran; Christina L Hutson; David Lowe; Chris N Mangal; Tyler Wolford; Audrey Matheny; Whitni Davidson; Kimberly Wilkins; Rachael Cook; Rebecca M Roulo; Michael K White; LaShondra Berman; Janna Murray; John Laurance; Drew Francis; Nicole M Green; Ricardo A Berumen; Anthony Gonzalez; Stacy Evans; Meghan Hudziec; Diane Noel; Michael Adjei; Gregory Hovan; Phil Lee; Lisa Tate; Remedios B Gose; Robert Voermans; Jennifer Crew; Phillip R Adam; Danielle Haydel; Salimatu Lukula; Nick Matluk; Sandip Shah; Joshua Featherston; Daphne Ware; Denise Pettit; Emily McCutchen; Edward Acheampong; Erin Buttery; Andrew Gorzalski; Michael Perry; Randal Fowler; Robert B Lee; Robert Nickla; Richard Huard; Amanda Moore; Katie Jones; Renee Johnson; Erin Swaney; Juan Jaramillo; Cynthia Reinoso Webb; Brandon Guin; Janine Yost; Annette Atkinson; Latoya Griffin-Thomas; Jessica Chenette; Jessica Gant; Alana Sterkel; Harjinder K Ghuman; James Lute; Sandra C Smole; Vaneet Arora; Courtney K Demontigny; Meilan Bielby; Evelyn Geeter; Kimberly A M Newman; Mark Glazier; Whitney Lutkemeier; Megan Nelson; Raymond Martinez; Jasmine Chaitram; Margaret A Honein; Julie M Villanueva
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2022-07-15       Impact factor: 35.301

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.